Clayton, Dubilier & Rice — the private investment firm behind some of the biggest distribution and industrial manufacturing transactions over the past decade — announced Nov. 21 that it has appointed ...

On July 7, building products distributor Beacon announced that it has reached an agreement with Clayton, Dubilier & Rice, LLC (CD&R) to repurchase all of the outstanding shares of its Series A ...

The latest update is out from Sealed Air ( (SEE)). On November 17, 2025, Sealed Air Corporation announced its acquisition by CD&R in an all-cash transaction valued at $10.3 billion, with stockholders ...

Multi-Color Corp.’s earnings were hit hard by lower customer demand in the third quarter as the label making firm’s debt obligations grow more daunting, according to people familiar with the situation ...

Claims that Cornerstone Building Brands Inc.‘s board manipulated the company’s forecasts amid pressure from Clayton, Dubilier & Rice LLC to approve a $5.8 billion take-private buyout will be resolved ...

Paris, April 30, 2025. Opella today becomes an independent global leader in consumer healthcare, marking a pivotal step in Sanofi's strategy. Sanofi announces today the closing of the sale to CD&R of ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to sell a 50% controlling stake of its consumer health business Opella for 10 ...

CD&R, the private equity owner of Focus Financial Partners, has tapped Charles Schwab’s former CFO, Peter Crawford, as an operating advisor to help evaluate and select new investments in the financial ...

ICG’s Strategic Equity unit has backed an innovative transaction that involves using secondaries capital via a continuation fund to take a listed asset private. TowerBrook Capital Partners and Clayton ...

Private equity firm Clayton, Dubilier & Rice has tapped former Anixter International CEO Bill Galvin as an operating advisor, leveraging his 36-year track record of executive leadership to support ...

Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling stake in Sanofi’s consumer health business could damage French interests, ...